|
US2014235576A1
|
|
Pyrrolidine-2-carboxylic acid derivatives as iglur antagonists
|
|
KR20140038435A
|
|
High-affinity, dimeric inhibitors of psd-95 as efficient neuroprotectants against ischemic brain damage and for treatment of pain
|
|
WO2010092057A1
|
|
Cold-active beta-galactosidase, a method of producing same and use of such enzyme
|
|
WO2009118010A1
|
|
A search method and a method of providing an electronic database
|
|
WO2009100724A1
|
|
Novel peptide derived from ncam (bcl)
|
|
WO2009034110A1
|
|
Prevention of type 1 diabetes by administration of gliadin
|
|
US2009029372A1
|
|
Adam12 as a biomarker for bladder cancer
|
|
WO2008086813A2
|
|
Peptides derived from proteins of the insulin super-family
|
|
US2010139759A1
|
|
Optical device
|
|
WO2008009292A1
|
|
An in vitro method for detection of inflammatory contaminants
|
|
US2009307788A1
|
|
Ribozyme mediated stabilization of polynucleotides
|
|
CA2645127A1
|
|
Inhibition of gasc1
|
|
BRPI0511435A
|
|
adam12, a new marker for abnormal cell function
|
|
EP1678741A1
|
|
Method of fabrication and device comprising elongated nanosize elements
|
|
AU2003291977A1
|
|
Compounds useful in the diagnosis and treatment of pregnancy-associated malaria
|
|
EP1536803A2
|
|
Use of bisphosphonic acid derivatives for the treatment of calcium phrophosphated deposition disease and dental treatment
|
|
AU2003223936A1
|
|
Method for purifying denatured proteins having a desired disulfide bond configuration
|
|
EP1414954A2
|
|
Epsti1, a gene induced by epithelial-stromal interaction in human breast cancer
|
|
US2002150914A1
|
|
Recombinant antibodies from a phage display library, directed against a peptide-MHC complex
|
|
EP1237403A1
|
|
Method of usinf mapk4 and orthologues thereof to control plant disease and plantgrowth
|
